Patient Input for Design of a Decision Support Smartphone Application for Type 1 Diabetes

Background: Decision support smartphone applications integrated with continuous glucose monitors may improve glycemic control in type 1 diabetes (T1D). We conducted a survey to understand trends and needs of potential users to inform the design of decision support technology. Methods: A 70-question survey was distributed October 2017 through May 2018 to adults aged 18-80 with T1D from a specialty clinic and T1D Exchange online health community (myglu.org). The survey responses were used to evaluate potential features of a diabetes decision support tool by Likert scale and open responses. Results: There were 1542 responses (mean age 46.1 years [SD 15.2], mean duration of diabetes 26.5 years [SD 15.8]). The majority (84.2%) have never used an app to manage diabetes; however, a large majority (77.8%) expressed interest in using a decision support app. The ability to predict and avoid hypoglycemia was the most important feature identified by a majority of the respondents, with 91% of respondents indicating the highest level of interest in these features. The task that respondents find most difficult was management of glucose during exercise (only 47% of participants were confident in glucose management during exercise). The respondents also highly desired features that help manage glucose during exercise (85% of respondents were interested). The responses identified integration and interoperability with peripheral devices/apps and customization of alerts as important. Responses from participants were generally consistent across stratified categories. Conclusions: These results provide valuable insight into patient needs in decision support applications for management of T1D.

[1]  Sofia Dahlqvist,et al.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial , 2017, JAMA.

[2]  Wilhelm Kirch,et al.  Mobile Applications for Diabetics: A Systematic Review and Expert-Based Usability Evaluation Considering the Special Requirements of Diabetes Patients Age 50 Years or Older , 2014, Journal of medical Internet research.

[3]  N. Hermanns,et al.  The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control , 2013, Health and Quality of Life Outcomes.

[4]  J. Hewitt,et al.  Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials , 2016, Diabetes Care.

[5]  S. Anderson,et al.  A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study , 2016, Diabetes Care.

[6]  J. Malcolm,et al.  Improving Glycemic Control in Adults and Children With Type 1 Diabetes With the Use of Smartphone-Based Mobile Applications: A Systematic Review. , 2019, Canadian journal of diabetes.

[7]  Ronald Tamler,et al.  An evaluation of diabetes self-management applications for Android smartphones , 2012, Journal of telemedicine and telecare.

[8]  S. Wild,et al.  Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. , 2015, JAMA.

[9]  Thomas Lumley,et al.  Analysis of Complex Survey Samples , 2004 .

[10]  Joseph Leitschuh,et al.  Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors , 2018, Diabetes Care.

[11]  Robin A. Paynter,et al.  Rapid Evidence Review of Mobile Applications for Self-management of Diabetes , 2018, Journal of General Internal Medicine.

[12]  H. Lehmann,et al.  Clinical Decision Support Systems (cdsss) Have Been Hailed for Their Potential to Reduce Medical Errors Clinical Decision Support Systems for the Practice of Evidence-based Medicine , 2022 .

[13]  José Tomás Prieto,et al.  Smartphone apps for calculating insulin dose: a systematic assessment , 2015, BMC Medicine.

[14]  Benyamin Grosman,et al.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes , 2017, Diabetes technology & therapeutics.

[15]  T. Christensen,et al.  Health and Quality of Life Outcomes , 2009 .

[16]  Howard Wolpert,et al.  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial , 2017, JAMA.

[17]  David Kerr,et al.  Overcoming Barriers to Adoption of Digital Health Tools for Diabetes , 2018, Journal of diabetes science and technology.

[18]  J. Bernhardt,et al.  Behavioral Functionality of Mobile Apps in Health Interventions: A Systematic Review of the Literature , 2015, JMIR mHealth and uHealth.

[19]  K. Kuehl,et al.  Randomized trial of a dual‐hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor‐augmented pump therapy , 2016, Diabetes, obesity & metabolism.

[20]  David M Maahs,et al.  Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry , 2015, Diabetes Care.